Johns Hopkins University School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2022

  1. Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

    American Journal of Geriatric Psychiatry, Vol. 30, Núm. 2, pp. 119-147

  2. Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 414-430

  3. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  4. Virtual Ontogeny of Cortical Growth Preceding Mental Illness

    Biological Psychiatry, Vol. 92, Núm. 4, pp. 299-313

2021

  1. Baseline Levels of C-Reactive Protein and Proinflammatory Cytokines Are Not Associated with Early Response to Amisulpride in Patients with First Episode Psychosis: The OPTiMiSE Cohort Study

    Schizophrenia Bulletin Open, Vol. 2, Núm. 1

2020

  1. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA

    NeuroImage, Vol. 218

2019

  1. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder

    Biological Psychiatry, Vol. 86, Núm. 7, pp. 545-556

2017

  1. Apathy associated with neurocognitive disorders: Recent progress and future directions

    Alzheimer's and Dementia, Vol. 13, Núm. 1, pp. 84-100

  2. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

    Journal of Alzheimer's Disease, Vol. 56, Núm. 3, pp. 929-938

2016

  1. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment

    Alzheimer's and Dementia, Vol. 12, Núm. 2, pp. 195-202

2010

  1. A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model

    Molecular Cancer Therapeutics, Vol. 9, Núm. 9, pp. 2582-2592

2007

  1. Effects of MDMA on blood glucose levels and brain glucose metabolism

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Núm. 6, pp. 916-925